Skip to main content
Equibles

ARTEMISMED · Artemis Medicare Services Limited · Financials

Use ARTEMISMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARTEMISMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
321.80 INR +5.05 (+1.59%) At close · Nov 13
Rebalance outlook locked
Market Cap
50.94B INR
Shares
158.31M
Volume · Nov 13 212.7K Avg daily vol (3M) 637.72K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
10.81B +15.4%
FY2026 Revenue FY2020–FY2026
Net Income
1.04B +25.4%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
1.32B -9.4%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 11.5B 10.81B 9.37B 8.79B 7.37B 5.55B 4.08B 5.65B
INR 524.26M 480.66M 451.65M 403.17M 310.04M 221.93M 215.14M 226.31M
INR 269.97M 276.87M 319.45M 312.87M 196.77M 119.75M 129.25M 127.98M
INR 1.54B 1.39B 1.08B 684.53M 506.06M 371.85M 75.3M 306.29M
INR 385.66M 354.63M 254.9M 193.08M 125.95M 57.83M 13.7M 111.69M
INR 1.15B 1.04B 826.26M 491.41M 358.98M 318.14M 61.6M 197.93M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 182.22M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.